<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2020.108021</article-id><article-id pub-id-type="publisher-id">OJGas-102484</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  A Simultaneous Multidisciplinary Evaluation of Irritable Bowel Syndrome in Egyptian Patients: Dietary, Psychiatric, Microbiologic and Autonomic Aspects
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Abdelbary</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>A.</surname><given-names>Al-Sayyad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Menesy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Nasreldin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>R.</surname><given-names>Mostafa</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>A.</surname><given-names>Nawito</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>R.</surname><given-names>Marzaban</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Giza, Egypt</addr-line></aff><aff id="aff1"><addr-line>Tropical Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt</addr-line></aff><aff id="aff5"><addr-line>Clinical Neurophysiology Department, Faculty of Medicine, Cairo University, Giza, Egypt</addr-line></aff><aff id="aff2"><addr-line>Gastrointestinal Endoscopy Unit, Cairo, Egypt</addr-line></aff><aff id="aff3"><addr-line>Psychiatry Department, Faculty of Medicine, Cairo University, Giza, Egypt</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>08</month><year>2020</year></pub-date><volume>10</volume><issue>08</issue><fpage>214</fpage><lpage>230</lpage><history><date date-type="received"><day>20,</day>	<month>July</month>	<year>2020</year></date><date date-type="rev-recd"><day>24,</day>	<month>August</month>	<year>2020</year>	</date><date date-type="accepted"><day>27,</day>	<month>August</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background and Aim:</b>
   Irritable bowel syndrome (IBS) is a common medical disorder that may be severe enough to impair the quality of life. This study aimed to assess the role of each of dietary, psychiatric, autonomic, and microbiology
   
  background and their interactions in Egyptian patients with IBS. <b>Patients and Methods:</b> Forty adult patients diagnosed with IBS, equally divided into 2 groups the diarrhea predominant and the constipation predominant, were recruited from the Endoscopy Unit. Dietary assessment was done by monthly food frequency questionnaire. Psychiatric assessment was done by both the Eysenck Personality Questionnaire (EPQ) and Hopkins Symptom Checklist (HSCL-90). Microbiologic evaluation was done by faecal cultures and neurophysiologic autonomic evaluation was done via the sympathetic skin response and the parasympathetic R-R interval variation. Another 20 healthy subjects were included as control group. <b>Results:</b> All IBS patients were young, with significant female predominance (P
   
  =
   
  0.007), particularly in IBS-C group (20/20; 100%, P
   
  =
   
  0.003). Psychologically, abnormal scores of neuroticism, extraversion and criminality, and depression, obsessive compulsion, somatization, sensitivity and anxiety in both IBS groups with particularly extraversion, criminality and depression were significantly higher in constipation subtype. Microbiologically, Bacteroid
  s 
  were significantly related to IBS, while Klebsiella was significantly deficient without significant difference between its groups. On the contrary, neither diet nor autonomic activity showed any significant relation. <b>Conclusions: </b>IBS is a disorder induced by many factors and affected by several interacting agents, thus revealing controversial results when studied simultaneously.
 
</p></abstract><kwd-group><kwd>Irritable Bowel Syndrome (IBS)</kwd><kwd> Eysenck Personality Questionnaire (EPQ)</kwd><kwd> Hopkins Symptom Checklist (HSCL-90)</kwd><kwd> Microbiota</kwd><kwd> Autonomic Activity</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Irritable bowel syndrome (IBS) is a common functional intestinal disorder constituting a major health complaint and is the most commonly diagnosed gut disease [<xref ref-type="bibr" rid="scirp.102484-ref1">1</xref>].</p><p>Pathogenesis of IBS is multifactorial: dietary (food sensitivity and carbohydrate malabsorption), microbiologic (altered fecal microbiota, bacterial overgrowth, and post infectious reactivity), and neurophysiologic (brain-gut interaction, altered gut motility, visceral hypersensitivity, intestinal inflammation) [<xref ref-type="bibr" rid="scirp.102484-ref2">2</xref>].</p><p>Patients may correlate ingestion of certain foods with their IBS complaints [<xref ref-type="bibr" rid="scirp.102484-ref1">1</xref>]. Dietary fermentable oligo-di-monosaccharides and polyols (FODMAP), a group that includes fructose, fructans, mannitol, lactose, xylitol, sorbitol, and galactans induces increased and prolonged hydrogen production in the intestine thus influencing the methane production, and eventually inducing local and systemic symptoms of IBS [<xref ref-type="bibr" rid="scirp.102484-ref2">2</xref>]. Conversely, low dietary FODMAP is effective in controlling IBS symptoms [<xref ref-type="bibr" rid="scirp.102484-ref3">3</xref>]. However, excessive diet restriction may lead to nutritional deficiencies. The suspected food is identified by the recurrence of symptoms once reintroduced in diet after being temporarily eliminated [<xref ref-type="bibr" rid="scirp.102484-ref4">4</xref>].</p><p>Anxiety, depression, and somatoform disorders are obviously associated with IBS [<xref ref-type="bibr" rid="scirp.102484-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref6">6</xref>]. Ten percent of the varied bowel symptoms are attributed to stress [<xref ref-type="bibr" rid="scirp.102484-ref6">6</xref>]. The psychiatric role in the pathogenesis of IBS was proved by the significant resolution by psychologic treatment [<xref ref-type="bibr" rid="scirp.102484-ref6">6</xref>], and the symptomatic relief by cognitive and hypnotherapies, and dynamic psychotherapy [<xref ref-type="bibr" rid="scirp.102484-ref7">7</xref>].</p><p>The role of small intestinal bacterial overgrowth in the pathogenesis of IBS was proved by the resolution of IBS when eradicated by antibiotics in 48% of subjects [<xref ref-type="bibr" rid="scirp.102484-ref8">8</xref>]. However, the benefit of antibiotics is transient and their exact mode of action is not clear whether treating small bowel bacterial overgrowth or altering gut microbiota [<xref ref-type="bibr" rid="scirp.102484-ref4">4</xref>].</p><p>Functional bowel disorders are associated with autonomic disturbance [<xref ref-type="bibr" rid="scirp.102484-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref10">10</xref>]. Heart rate variability (HRV) has considerable potential to assess the role of autonomic nervous system (ANS) fluctuations in normal healthy individuals and in patients [<xref ref-type="bibr" rid="scirp.102484-ref11">11</xref>], and skin sympathetic response (SSR) is a simple bed side test strongly correlated with diseases where dysautonomia was incriminated [<xref ref-type="bibr" rid="scirp.102484-ref12">12</xref>]. ANS assessment may be considered a new modality for clinical management of IBS [<xref ref-type="bibr" rid="scirp.102484-ref13">13</xref>].</p><p>This study aimed at evaluating the dietary, psychiatric, microbiologic and autonomic nervous activity of IBS patients.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a cohort simultaneous multidisciplinary evaluation of IBS. The study included patients attending the colonoscopy room at Gastrointestinal (GI) Endoscopy Unit, Kasr El-Ainy, Faculty of Medicine, Cairo University, Egypt and presented with variable lower, non-alarming GI symptoms, and with normal colonic macroscopic and microscopic examination. Colonoscopic biopsies were done to exclude any organic pathology including those with normal overlying mucosa. Upper endoscopy with duodenal biopsy was done in cases simulating IBS like Celiac disease.</p><sec id="s2_1"><title>2.1. Inclusion Criteria</title><p>&#183; Adult patients (≥ 18 years old);</p><p>&#183; Both genders;</p><p>&#183; Fulfilling the Rome III criteria [<xref ref-type="bibr" rid="scirp.102484-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref15">15</xref>] i.e. at least three months of continuous or recurrent abdominal pain or discomfort that has two or more of the following features: improvement with defecation, association with a change in the frequency, and a change in stool form.</p></sec><sec id="s2_2"><title>2.2. Exclusion Criteria</title><p>All organic colonic diseases that may simulate IBS clinical picture and any medications that may interfere with the applied tests of the test whether directly or indirectly.</p><p>&#183; Celiac serology;</p><p>&#183; Organic GI pathology;</p><p>&#183; Alarming symptoms (e.g. significant weight loss, bloody diarrhea, cachexia).</p><p>&#183; Organic neurologic affection;</p><p>&#183; Medical condition affecting the brain—gut neurogenic pathways or any form of neuropathies; Special habits (alcoholism), Endocrinal, Cardiovascular diseases;</p><p>&#183; Medications interfering with tests carried out.</p><p>Patients were equally divided into two groups according to their predominant motion; IBS-D and IBS-C. Twenty healthy volunteers participated in this work as control group.</p><p>All enrolled patients and control subjects were subjected to:</p><p>1) Full history taking: a) Complaint: constipation vs. diarrhea, frequency, passage of blood, mucous in stools, site of pain, distension, flatus, tenesmus, anal itching, passage of worms. b) Medical history. c) Dietary history e.g. Monthly food frequency questionnaire about common fermentable oligo-di-monosaccharides and polyols (FODMAP) foods in Egypt. It was composed of ingestion of beans, lentils/peas, refined bread, milk/dairy products, skinned vegetables/fruits, coffee, sweets/candies, carbonated beverages, cakes/cookies/pasta, rice, and large fatty meals. 2) Thorough clinical examination: a) General, b) Psychiatric assessment: The psychological profile of the patients was done provided that the Arabic certified translation was attached, by utilizing the following two tests. i) The Eysenck Personality Questionnaire (EPQ) [<xref ref-type="bibr" rid="scirp.102484-ref16">16</xref>]. It is composed of 90 statements of which subjects respond by “Yes” or “No”. It has 5 scales that measure the dimensions of psychoticism, neuroticism, extraversion-introversion, lie, and criminality, provided that each one has its normal psychological range, and ii) The Hopkins Symptom Checklist (HSCL-90) scale [<xref ref-type="bibr" rid="scirp.102484-ref17">17</xref>]. It is a self-rating test to indicate how much he/she is distressed by each of 90 possible symptoms. This test is further scored for 9 clinical scales: somatization, obsessive-compulsive symptoms, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. Scale &gt; 20 is considered significantly positive. 3) Investigatory work up: a) Microbiologic assessment: Faecal microbiota were examined by repeated stool cultures to exclude infectious causes, and to identify faecal microbiota regarding type and count. Stool samples were cultured on i) a panel of selective and enriched media under aerobic and anaerobic conditions. Isolated microorganisms will be phenotypically identified by conventional biochemical testing and ii) an automated bacterial identification system; namely the VITEK&#174; 2 system (bioM&#233;rieux). Representative species of fecal bacterial flora will be cultured quantitatively, and further categorized as mild (1 − 999 &#215; 10<sup>5</sup> CFU)/ml), moderate (1000 − 99,999 &#215; 10<sup>5</sup> CFU/ml) &amp; high (≥100,000 &#215; 10<sup>5</sup> CFU/ml). b) Biochemical blood routine tests, c) Imaging i.e. Abdominal Ultrasound. d) Neurophysiologic Autonomic activity assessment: Autonomic activity is assessed by sympathetic skin response (SSR) [<xref ref-type="bibr" rid="scirp.102484-ref18">18</xref>], and R-R interval variation (RRIV) [<xref ref-type="bibr" rid="scirp.102484-ref11">11</xref>] which are noninvasive procedures to assess the autonomic nervous functions. SSR and RRIV were recorded using a Nihon Kohden Neuropack apparatus&#174; (Tokyo, Japan) in the Clinical Neurophysiology Unit, Kasr AlAiny Hospital. i) The SSR was recorded from the upper limb by attaching surface electrodes on the right hand with application of electrically stimuli to the left wrist. For the SSR the onset latency in seconds was calculated. ii) The RRIV was acquired at rest (RRIV) and during deep breathing (RRIV-D) [<xref ref-type="bibr" rid="scirp.102484-ref19">19</xref>]. The coefficient of variation (CV) was calculated to represent the RRIV. e) Statistical analysis: Data were entered on the computer using “Microsoft Office Excel Software” program (2010) for windows. Data were then transferred to the Statistical Package of Social Science Software program, version 23 (IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.) to be statistically analyzed. Data were presented using range, mean, standard deviation (SD) and median for quantitative variables, and frequency and percentage for qualitative ones. Comparison between groups was performed using Kruskal Wallis test with Mann Whitney test for pairwise comparisons for quantitative variables and Chi square or Fisher’s exact test for qualitative ones. Spearman correlation coefficients were calculated to assess the association between different quantitative and ordinal variables. P &lt; 0.05 is considered statistically significant. In non-normally distributed data, P value was calculated via non parametric test. f) Ethical consideration: This study was conducted according to the declaration of Helsinki and was approved by the ethical committee of Tropical Medicine Department, Faculty of Medicine, Cairo University. A fully informative consent was signed by the IBS patients and control subjects but it was not presented for the personal data that may identify the patients.</p></sec></sec><sec id="s3"><title>3. Results</title><p>This study included 40 adult patients who attended the colonoscopy room of the Gastrointestinal Endoscopy Unit at Kasr El-Ainy Hospital, Faculty of Medicine, Cairo University. They were diagnosed to have IBS according to Rome III criteria. They were enrolled from June 2016 to January 2018 out of 335 referred colonoscopy cases (11.94%).</p><p>The 40 IBS patients were divided into two equal groups; IBS-D and IBS-C, and 20 other healthy subjects serving as control group.</p><p>The basic personal data and complaints are shown in <xref ref-type="table" rid="table1">Table 1</xref>. All of the patients were young, insignificantly and mildly older IBS-C group, and predominantly females, particularly in IBS-C. Course of the complaint in both IBS groups was stationary. All of them were clinically free.</p><p>Dietary assessment of the studied groups is shown in <xref ref-type="table" rid="table2">Table 2</xref>. None of the questioned food types was significantly related to any of the studied groups.</p><p>The psychiatric assessment of the studied groups via EPQ scale and HSCL-90 in terms of their absolute score is shown in <xref ref-type="table" rid="table3">Table 3</xref>. All the parameters, except extraversion and lie of EPQ, were significantly higher in both IBS groups, and mostly with insignificant interdifference.</p><p>However, for many of the recorded scores lied within the normal psychologic range, the percent of patients who recorded abnormal psychiatric scores in EPQ and HSCL-90 were illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref> respectively to show the true and definite psychiatric trait.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Basic personal data and complaint of the studied IBS patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Basic personal data and complaint<sup>a</sup></th><th align="center" valign="middle"  rowspan="2"  >IBS-D n = 20</th><th align="center" valign="middle"  rowspan="2"  >IBS-C n = 20</th><th align="center" valign="middle"  rowspan="2"  >Control n = 20</th><th align="center" valign="middle"  colspan="4"  >P value</th></tr></thead><tr><td align="center" valign="middle" >P1</td><td align="center" valign="middle" >P2</td><td align="center" valign="middle" >P3</td><td align="center" valign="middle" >P4</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Personal</td><td align="center" valign="middle" >Age in years</td><td align="center" valign="middle" >32.9 &#177; 10.1</td><td align="center" valign="middle" >34.2 &#177; 9.5</td><td align="center" valign="middle" >32.7 &#177; 7.7</td><td align="center" valign="middle" >0.921</td><td align="center" valign="middle" >0.807</td><td align="center" valign="middle" >0.914</td><td align="center" valign="middle" >0.674</td></tr><tr><td align="center" valign="middle" >Males/females</td><td align="center" valign="middle" >8/12 (40/60)</td><td align="center" valign="middle" >0/20 (0/100)</td><td align="center" valign="middle" >4/16 (20/80)</td><td align="center" valign="middle" >0.007</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >0.301</td><td align="center" valign="middle" >0.106</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Complaint</td><td align="center" valign="middle" >Onset in months</td><td align="center" valign="middle" >47.1 &#177; 39.1 36 (6 - 144)</td><td align="center" valign="middle" >63.4 &#177; 70.6 30 (6 - 240)</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="4"   rowspan="2"  ></td></tr><tr><td align="center" valign="middle" >Pattern</td><td align="center" valign="middle" >2 - 4 motions/day 3 (2 - 3)</td><td align="center" valign="middle" >Once within 2 - 5 days 3 (3 - 4)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>a</sup>Quantitative parameters are expressed in mean &#177; standard deviation, median (Inter quartile range), while qualitative parameters are expressed in number (percent). IBS-D = Irritable bowel disease-diarrhea, IBS-C = Irritable bowel disease-constipation. P1 = overall, P2 = IBS-D versus IBS-C, P3 = IBS-D versus control, P4 = IBS-C versus control.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Nutritional assessment via diet questionnaire of the studied groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Foods of Diet Questionnaire</th><th align="center" valign="middle"  colspan="2"  >IBS-D (n = 20)</th><th align="center" valign="middle"  colspan="2"  >IBS-C (n = 20)</th><th align="center" valign="middle"  colspan="2"  >Control (n = 20)</th><th align="center" valign="middle"  rowspan="2"  >P value (overall)</th></tr></thead><tr><td align="center" valign="middle" >Prevalence n (%)</td><td align="center" valign="middle" >Frequency Mean &#177; SD median (IQR)</td><td align="center" valign="middle" >Prevalence n (%)</td><td align="center" valign="middle" >Frequency Mean &#177; SD median (IQR)</td><td align="center" valign="middle" >Prevalence n (%)</td><td align="center" valign="middle" >Frequency Mean &#177; SD median (IQR)</td></tr><tr><td align="center" valign="middle" >Beans</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >21 &#177; 10.2 25 (12 - 30)</td><td align="center" valign="middle" >17 (85)</td><td align="center" valign="middle" >19.4 &#177; 12.2 23 (10 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >16.3 &#177; 11.7 12 (6 - 30)</td><td align="center" valign="middle" >0.425</td></tr><tr><td align="center" valign="middle" >Lentils</td><td align="center" valign="middle" >16 (80)</td><td align="center" valign="middle" >4.8 &#177; 9 1.5 (1 - 2.5)</td><td align="center" valign="middle" >16 (80)</td><td align="center" valign="middle" >6.4 &#177; 11.1 1 (1 - 2)</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >1.4 &#177; 0.8 1 (1 - 2)</td><td align="center" valign="middle" >0.742</td></tr><tr><td align="center" valign="middle" >Refined bread</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >1.5 &#177; 6.7 0 (0)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 &#177; 0 0 (0)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 &#177; 0 0 (0)</td><td align="center" valign="middle" >0.368</td></tr><tr><td align="center" valign="middle" >Milk &amp; dairy products</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >12.8 &#177; 10.8 8 (3.5 - 23)</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >16.6 &#177; 15.4 10 (5.5 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >15.3 &#177; 10.2 12 (8 - 30)</td><td align="center" valign="middle" >0.528</td></tr><tr><td align="center" valign="middle" >Skinned vegetables</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >1.1 &#177; 4.5 0 (0)</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0.1 &#177; 0.2 0 (0)</td><td align="center" valign="middle" >3 (15)</td><td align="center" valign="middle" >2.5 &#177; 7.2 0 (0)</td><td align="center" valign="middle" >0.528</td></tr><tr><td align="center" valign="middle" >Skinned fruits</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 &#177; 0 0 (0)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 &#177; 0 0 (0)</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >1.6 &#177; 6.7 0 (0)</td><td align="center" valign="middle" >0.131</td></tr><tr><td align="center" valign="middle" >Sweets &amp; candies</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >4.3 &#177; 4.7 2 (1 - 8)</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >4.8 &#177; 6.6 2 (1 - 8)</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >4.7 &#177; 3 4 (2 - 8)</td><td align="center" valign="middle" >0.470</td></tr><tr><td align="center" valign="middle" >Coffee</td><td align="center" valign="middle" >17 (85)</td><td align="center" valign="middle" >17.3 &#177; 16 14 (1.5 - 30)</td><td align="center" valign="middle" >16 (80)</td><td align="center" valign="middle" >19.8 &#177; 24.8 8 (2.5 - 30)</td><td align="center" valign="middle" >18 (90)</td><td align="center" valign="middle" >15.9 &#177; 16.5 8 (3 - 30)</td><td align="center" valign="middle" >0.957</td></tr><tr><td align="center" valign="middle" >Carbonated drinks</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >13.1 &#177; 10 12 (4 - 16)</td><td align="center" valign="middle" >18 (90)</td><td align="center" valign="middle" >10.3 &#177; 9.7 8 (2 - 12)</td><td align="center" valign="middle" >19 (95)</td><td align="center" valign="middle" >12 &#177; 10.2 8 (5 - 14)</td><td align="center" valign="middle" >0.523</td></tr><tr><td align="center" valign="middle" >Rice</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >25.7 &#177; 6.3 30 (20 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >25.5 &#177; 8.5 30 (25 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >19.6 &#177; 10 14 (12 - 30)</td><td align="center" valign="middle" >0.052</td></tr><tr><td align="center" valign="middle" >Cake, cookies, pasta</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >19.8 &#177; 16.1 14 (8 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >17.6 &#177; 9.5 16 (10 - 30)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >11.5 &#177; 6 10 (8 - 14)</td><td align="center" valign="middle" >0.081</td></tr><tr><td align="center" valign="middle" >Large fatty meal</td><td align="center" valign="middle" >18 (90)</td><td align="center" valign="middle" >2.7 &#177; 3.8 1 (1 - 2)</td><td align="center" valign="middle" >14 (70)</td><td align="center" valign="middle" >3.4 &#177; 6.8 1 (0 - 3)</td><td align="center" valign="middle" >14 (70)</td><td align="center" valign="middle" >2.4 &#177; 6.5 1 (0 - 1.5)</td><td align="center" valign="middle" >0.305</td></tr></tbody></table></table-wrap><p>IBS-D = Irritable bowel syndrome diarrhea predominant, IBS-C = Irritable bowel syndrome constipation predominant, SD = Standard deviation, IQR = Interquartile range.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Psychiatric assessment of the studied groups in terms of its absolute score</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Psychologic assessment</th><th align="center" valign="middle"  colspan="3"  >Mean &#177; SD Median (IQR)</th><th align="center" valign="middle"  colspan="4"  >P value</th></tr></thead><tr><td align="center" valign="middle" >IBS-D (n = 20)</td><td align="center" valign="middle" >IBS-C (n = 20)</td><td align="center" valign="middle" >Control (n = 20)</td><td align="center" valign="middle" >P1</td><td align="center" valign="middle" >P2</td><td align="center" valign="middle" >P3</td><td align="center" valign="middle" >P4</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >EPQ scale</td><td align="center" valign="middle" >Psychotism</td><td align="center" valign="middle" >5.9 &#177; 2.3 6 (4 - 7)</td><td align="center" valign="middle" >6.1 &#177; 1.8 6 (5 - 7)</td><td align="center" valign="middle" >5.8 &#177; 2.1 5.5 (4 - 7.5)</td><td align="center" valign="middle" >0.817</td><td align="center" valign="middle" >0.601</td><td align="center" valign="middle" >0.946</td><td align="center" valign="middle" >0.565</td></tr><tr><td align="center" valign="middle" >Neuroticism</td><td align="center" valign="middle" >18.1 &#177; 3.5 19 (15.5 - 21)</td><td align="center" valign="middle" >20.4 &#177; 1.1 20.5 (20 - 21)</td><td align="center" valign="middle" >14.5 &#177; 3.8 15 (12 - 16.5)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.021</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Extraversion</td><td align="center" valign="middle" >7.9 &#177; 5.2 6.5 (4 - 11.5)</td><td align="center" valign="middle" >5.7 &#177; 3.4 5.5 (2.5 - 8)</td><td align="center" valign="middle" >13 &#177; 4 13 (10 - 16.5)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.222</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Lie</td><td align="center" valign="middle" >9.9 &#177; 2.7 9.5 (8.5 - 12)</td><td align="center" valign="middle" >11.3 &#177; 2.2 11 (10 - 12.5)</td><td align="center" valign="middle" >10.6 &#177; 2.5 10.5 (9 - 11.5)</td><td align="center" valign="middle" >0.110</td><td align="center" valign="middle" >0.129</td><td align="center" valign="middle" >0.435</td><td align="center" valign="middle" >0.170</td></tr><tr><td align="center" valign="middle" >Criminality</td><td align="center" valign="middle" >15.6 &#177; 2.1 15.5 (14 - 16.5)</td><td align="center" valign="middle" >17.1 &#177; 2 17 (16 - 18)</td><td align="center" valign="middle" >13 &#177; 3.7 11.5 (10 - 16)</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.014</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle"  rowspan="9"  >HSCL-90</td><td align="center" valign="middle" >Psychoticism</td><td align="center" valign="middle" >14.7 &#177; 5.7 13.5 (11 - 18.5)</td><td align="center" valign="middle" >15.9 &#177; 5.1 15 (12.5 - 18)</td><td align="center" valign="middle" >7.8 &#177; 4 7 (5 - 9.5)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.481</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Paranoia</td><td align="center" valign="middle" >9.4 &#177; 2.7 9 (8 - 11)</td><td align="center" valign="middle" >9.9 &#177; 2 10 (9 - 11)</td><td align="center" valign="middle" >6.4 &#177; 2.7 6 (4 - 9)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.206</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Phobic anxiety</td><td align="center" valign="middle" >8.4 &#177; 4.1 9 (5 - 10)</td><td align="center" valign="middle" >8.7 &#177; 4.1 8 (6 - 12)</td><td align="center" valign="middle" >3.3 &#177; 2.4 3 (2 - 4)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.664</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Hostility</td><td align="center" valign="middle" >6.7 &#177; 3.1 6 (5 - 8)</td><td align="center" valign="middle" >7.1 &#177; 2.4 7 (5 - 9)</td><td align="center" valign="middle" >3.9 &#177; 0.8 4 (3 - 4)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.530</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Anxiety</td><td align="center" valign="middle" >15.7 &#177; 5.5 16 (11.5 - 18.5)</td><td align="center" valign="middle" >18.2 &#177; 5.8 19 (14.5 - 22)</td><td align="center" valign="middle" >9.4 &#177; 3.4 10 (8 - 10.5)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.143</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Depression</td><td align="center" valign="middle" >27.4 &#177; 7 27.5 (24.5 - 31)</td><td align="center" valign="middle" >29.3 &#177; 5.4 29.5 (28 - 31)</td><td align="center" valign="middle" >17.7 &#177; 4.2 19 (14 - 20)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.232</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Interpersonal sensitivity</td><td align="center" valign="middle" >17.7 &#177; 5.4 20 (16.5 - 21)</td><td align="center" valign="middle" >19.5 &#177; 4.4 19 (17 - 21)</td><td align="center" valign="middle" >12.5 &#177; 3.8 13 (10 - 16)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.849</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Obsessive compulsive</td><td align="center" valign="middle" >19.9 &#177; 3.9 20 (19 - 22)</td><td align="center" valign="middle" >20.2 &#177; 3.4 20.5 (18 - 22)</td><td align="center" valign="middle" >13.9 &#177; 3.6 14.5 (13 - 16)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.744</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Somatization</td><td align="center" valign="middle" >19.7 &#177; 8.4 17.5 (13.5 - 22)</td><td align="center" valign="middle" >20.7 &#177; 8.7 18 (15 - 25.5)</td><td align="center" valign="middle" >8.1 &#177; 3.5 8.5 (6 - 10.5)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.645</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>EPQ = Eysenck’s personality questionnaire, HSCL-90 = Hopkins symptom checklist, IBS-D = Irritable bowel disease-diarrhea, IBS-C = Irritable bowel disease-constipation, SD = Standard deviation, IQR = Interquartile range, P1 = overall, P2 = IBS-D versus IBS-C, P3 = IBS-D versus control, P4 = IBS-C versus control.</p><p>Fecal microbiota of the studied groups by the conventional cultures and the automated VITEK test are shown in <xref ref-type="table" rid="table4">Table 4</xref>. Aspergillus was significantly high in IBS-C however fungal detection was generally very low.</p><p>The ANS assessment of the studied groups is shown in <xref ref-type="table" rid="table5">Table 5</xref>. Neither the sympathetic nor the parasympathetic showed statistically significant relation with any of the studied groups.</p><p>Correlation tests were done between every 2 of the 4 studied aspects in which IBS groups were merged together for 1) most of the previous results showed a significant difference between each of IBS groups and the control one but not between them, and 2) the rather small number of patients. Significant correlations were found in very few items. Correlation results were expressed in many and lengthy tables, thus not included in the manuscript.</p><table-wrap-group id="4"><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Fecal microbiota of the studied groups</title></caption><table-wrap id="4_1"><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="3"  >Organisms’ species by standard culture</th><th align="center" valign="middle"  colspan="4"  >IBS-D (n =20)</th><th align="center" valign="middle"  colspan="4"  >IBS-C (n = 20)</th><th align="center" valign="middle"  colspan="4"  >Controls (n = 20)</th><th align="center" valign="middle"  rowspan="3"  >P value (Overall)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Prevalence (%)</td><td align="center" valign="middle"  colspan="3"  >Degree</td><td align="center" valign="middle"  rowspan="2"  >Prevalence (%)</td><td align="center" valign="middle"  colspan="3"  >Degree</td><td align="center" valign="middle"  rowspan="2"  >Prevalence (%)</td><td align="center" valign="middle"  colspan="3"  >Degree</td></tr><tr><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Marked</td><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Marked</td><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >Marked</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Coliform (enterobacterica)</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >15.8</td><td align="center" valign="middle" >42.1</td><td align="center" valign="middle" >42.1</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >15.8</td><td align="center" valign="middle" >68.4</td><td align="center" valign="middle" >15.8</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >26.3</td><td align="center" valign="middle" >36.8</td><td align="center" valign="middle" >36.8</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle"  colspan="2"  >E. col</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >16.7</td><td align="center" valign="middle" >38.9</td><td align="center" valign="middle" >44.4</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >26.3</td><td align="center" valign="middle" >63.2</td><td align="center" valign="middle" >10.5</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >22.2</td><td align="center" valign="middle" >44.4</td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" >0.804</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Klebsiella</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41.7</td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" >0.030</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Other (non fermenters)</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >66.7</td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.235</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Aerobic gram positive</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >56.3</td><td align="center" valign="middle" >18.8</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >31.6</td><td align="center" valign="middle" >63.2</td><td align="center" valign="middle" >5.3</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >52.9</td><td align="center" valign="middle" >35.3</td><td align="center" valign="middle" >11.8</td><td align="center" valign="middle" >0.364</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Staphylococci</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >27.3</td><td align="center" valign="middle" >72.7</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >54.5</td><td align="center" valign="middle" >36.4</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" >0.176</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Enterococci</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >30.8</td><td align="center" valign="middle" >61.5</td><td align="center" valign="middle" >7.7</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >28.6</td><td align="center" valign="middle" >64.3</td><td align="center" valign="middle" >7.1</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >64.7</td><td align="center" valign="middle" >35.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.216</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Diphtheroid</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >57.1</td><td align="center" valign="middle" >42.9</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >83.3</td><td align="center" valign="middle" >16.7</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.155</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Bifidobacterium</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >20</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0.180</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Eubacterium</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41.7</td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >18.8</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >31.3</td><td align="center" valign="middle" >80</td><td align="center" valign="middle" >6.3</td><td align="center" valign="middle" >43.8</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >0.256</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Veillonella</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >37.5</td><td align="center" valign="middle" >62.5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >61.5</td><td align="center" valign="middle" >38.5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.281</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Peptostreptococci/Ruminococcus</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >16.7</td><td align="center" valign="middle" >66.7</td><td align="center" valign="middle" >16.7</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >6.7</td><td align="center" valign="middle" >73.3</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >7.7</td><td align="center" valign="middle" >76.9</td><td align="center" valign="middle" >15.4</td><td align="center" valign="middle" >0.592</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Fusobacterium</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >28.6</td><td align="center" valign="middle" >57.1</td><td align="center" valign="middle" >14.3</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >37.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >7.7</td><td align="center" valign="middle" >76.9</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >0.125</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Bacterotides</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >17.6</td><td align="center" valign="middle" >52.9</td><td align="center" valign="middle" >29.4</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" >66.7</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >8.3</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >41.7</td><td align="center" valign="middle" >0.048</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Prevotella</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" >45.5</td><td align="center" valign="middle" >45.5</td><td align="center" valign="middle" >0.627</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Clostridium</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >7.1</td><td align="center" valign="middle" >57.1</td><td align="center" valign="middle" >35.7</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >53.8</td><td align="center" valign="middle" >46.2</td><td align="center" valign="middle" >0.400</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Actinomyces</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.364</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Fungus</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >85.7</td><td align="center" valign="middle" >14.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.024</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Candida</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Aspergillus</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >30</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Organisms’ species by VITIC culture</td><td align="center" valign="middle"  colspan="4"  ></td><td align="center" valign="middle"  colspan="4"  ></td><td align="center" valign="middle"  colspan="4"  ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Non fermenters</td><td align="center" valign="middle" >Serratia</td><td align="center" valign="middle"  colspan="4"  >0</td><td align="center" valign="middle"  colspan="4"  >2 (10)</td><td align="center" valign="middle"  colspan="4"  >0</td><td align="center" valign="middle" >0.126</td></tr><tr><td align="center" valign="middle" >Proteus</td><td align="center" valign="middle"  colspan="4"  >1 (5)</td><td align="center" valign="middle"  colspan="4"  >1 (5)</td><td align="center" valign="middle"  colspan="4"  >1 (5)</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Pseudomonas</td><td align="center" valign="middle"  colspan="4"  >1 (5)</td><td align="center" valign="middle"  colspan="4"  >3 (15)</td><td align="center" valign="middle"  colspan="4"  >0</td><td align="center" valign="middle" >0.153</td></tr></tbody></table></table-wrap><table-wrap id="4_2"><table><tbody><thead><tr><th align="center" valign="middle" >Veillonella</th><th align="center" valign="middle" >Megasheria</th><th align="center" valign="middle" >0</th><th align="center" valign="middle" >1 (5)</th><th align="center" valign="middle" >0</th><th align="center" valign="middle" >0.362</th></tr></thead><tr><td align="center" valign="middle" >Peptostreptococci</td><td align="center" valign="middle" >Peptoniphilus asaccharolytica</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle" >Fusobacterium</td><td align="center" valign="middle" >F. mortiferum</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle"  rowspan="6"  >Bacteroids</td><td align="center" valign="middle" >B. fragilis</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >6 (30)</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0.064</td></tr><tr><td align="center" valign="middle" >B. vulgatus</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle" >B. ovatus</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3 (15)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.129</td></tr><tr><td align="center" valign="middle" >B. thetaiotamicron</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle" >B. stercoris</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle" >Parabacteroids distasonis</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Prevotella</td><td align="center" valign="middle" >P. melaninogenica</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >P. oralis</td><td align="center" valign="middle" >7 (35)</td><td align="center" valign="middle" >6 (30)</td><td align="center" valign="middle" >6 (30)</td><td align="center" valign="middle" >0.926</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Clostridium</td><td align="center" valign="middle" >C. sordelii</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.349</td></tr><tr><td align="center" valign="middle" >C. perfringens</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.126</td></tr><tr><td align="center" valign="middle" >C. Clostridioforme</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 (5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.362</td></tr><tr><td align="center" valign="middle" >C. sporogenes</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2 (10)</td><td align="center" valign="middle" >0.126</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> The autonomic activity in the three studied groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Autonomic parameters</th><th align="center" valign="middle"  colspan="3"  >Mean &#177; SD Median (IQR)</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >IBS-D (n = 20)</td><td align="center" valign="middle" >IBS-C (n = 20)</td><td align="center" valign="middle" >Control (n = 20)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Para Sympathetic (coefficient)</td><td align="center" valign="middle" >RRIV</td><td align="center" valign="middle" >7.7 &#177; 8.3 4.1 (2.3 - 10.8)</td><td align="center" valign="middle" >9 &#177; 10.9 4.8 (2.5 - 8.3)</td><td align="center" valign="middle" >8.5 &#177; 8.2 4.5 (3.3 - 10.5)</td><td align="center" valign="middle" >0.875</td></tr><tr><td align="center" valign="middle" >RRIV-D</td><td align="center" valign="middle" >18.5 &#177; 10.8 19.7 (12.1 - 27)</td><td align="center" valign="middle" >28.1 &#177; 24.1 20.1 (9.5 - 5.8)</td><td align="center" valign="middle" >19.7 &#177; 13.5 15.1 (11.2 - 26.8)</td><td align="center" valign="middle" >0.657</td></tr><tr><td align="center" valign="middle" >Sympathetic</td><td align="center" valign="middle" >SSR in seconds</td><td align="center" valign="middle" >2.5 &#177; 1.6 1.8 (1.2 - 4.1)</td><td align="center" valign="middle" >1.3 &#177; 0.5 1.3 (1 - 1.5)</td><td align="center" valign="middle" >1.8 &#177; 1.6 1.3 (1 - 1.7)</td><td align="center" valign="middle" >0.079</td></tr></tbody></table></table-wrap><p>RRIV: R-R interval variation, RRIV-D: R-R interval variation during deep breathing, SSR: Sympathetic skin response.</p><p>Beans showed the broadest (6/9 items) significant negative correlation with HSCL-90. Lentils were positively correlated with Enterococci and Actinomyces, sweets and candies were positively correlated with Klebsiella, rice was negatively correlated with Staph. aureus. Large fatty meals were positively correlated with the parasympathetic activity at both rest and deep breath tests, but neither food nor psychiatric assessment showed significant correlation with the sympathetic activity. Sympathetic activity was positively correlated with Staph. aureus, and negatively correlated with Prevotella, while the parasympathetic activity showed positive correlation with Klebsiella at rest.</p></sec><sec id="s4"><title>4. Discussion</title><p>IBS is the clinical challenge in this century. It is the most commonly diagnosed GI disorder [<xref ref-type="bibr" rid="scirp.102484-ref20">20</xref>]. IBS is the most common complaint in gastroenterology clinics [<xref ref-type="bibr" rid="scirp.102484-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref20">20</xref>].</p><p>In this study, the prevalence of IBS among patients referred to colonoscopy unit was 11.94%. This percent was close to prevalence in several previous studies. Drossman et al., 2002 stated that almost 12% of IBS patients sought medical advice at primary care centers constituting the largest group in gastroenterology clinics [<xref ref-type="bibr" rid="scirp.102484-ref1">1</xref>], Talley, 1999 found that approximately 10% - 15% of the general population have IBS [<xref ref-type="bibr" rid="scirp.102484-ref21">21</xref>], and Spiller et al., 2007 stated that it affects 5% - 11% of population of most countries [<xref ref-type="bibr" rid="scirp.102484-ref22">22</xref>]. It is worth mentioning that that percent in this study is like the iceberg overlying a huge number of masked patients, because the included patients are those who suffered from symptoms that were severe enough to be evaluated colonoscopically. Those with mild and moderate symptoms, besides those who do not seek medical advice were beyond our scope. Higher prevalence was reported by Meleine &amp; Matricon, 2014 who recorded a prevalence of one IBS patient in five people at some point in their lives, and this ratio has a significantly negative impact of both quality of life and the utility of health care centers [<xref ref-type="bibr" rid="scirp.102484-ref23">23</xref>].</p><p>All of the IBS patients in this study were young (mean age = 33.6 &#177; 9.7 years, IBS-D slightly younger). This agreed with Spiller et al who diagnosed IBS peak in 3<sup>rd</sup> and 4<sup>th</sup> decades [<xref ref-type="bibr" rid="scirp.102484-ref22">22</xref>].</p><p>Females were significantly predominant in IBS patients in this study (P = 0.007), particularly in IBS-C who were all females (P = 0.003), while all IBS male patients belonged to IBS-D. This was found in many previous results [<xref ref-type="bibr" rid="scirp.102484-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref22">22</xref>]. That was explained by Meleine &amp; Matricon who stated that the fluctuation of ovarian hormones along the menstrual cycle affects the sensorimotor gastrointestinal function. They influence IBS onset and the pattern of its symptoms. They alter pain processing and perception by interacting with both the neuromodulatory and emotional systems. They also modulate the susceptibility and hyper-responsiveness to stress which promote immune activation or impair gut barrier function [<xref ref-type="bibr" rid="scirp.102484-ref23">23</xref>]. Hattori &amp; Fukudo, 2006 stated that females have lower pain threshold, and conversely males have greater sympathovagal balance in response to visceral stimulation who found 2/3 of their IBS patients were females [<xref ref-type="bibr" rid="scirp.102484-ref24">24</xref>]. Also, Heitkemper &amp; Jarrett, 2008 found IBS patients seeking medical advice are mainly women for several reasons; inherent different gonadal hormones, inflammatory responses, stress reactivity, and sociocultural differences in response to pain and/or bowel pattern changes [<xref ref-type="bibr" rid="scirp.102484-ref25">25</xref>].</p><p>In this study none of the foods was related to IBS symptoms which were contrary to the previous results. Patients correlated foods such as caffeine, fatty foods, carbonated foods, or gas-producing foods, and alcoholic beverages as the etiology of their complaints [<xref ref-type="bibr" rid="scirp.102484-ref1">1</xref>]. Food plays a critical role in pathogenesis of IBS, and most patients associated its onset or exacerbation of its symptoms after certain meals. Conversely, diet low in fermentable, poorly absorbed carbohydrates and sugar alcohols is beneficial in resolving IBS symptoms [<xref ref-type="bibr" rid="scirp.102484-ref26">26</xref>]. In addition, increasing dietary content of soluble fiber (psyllium) significantly relieves and reduces the severity of symptoms, to the contrary the insoluble fiber (bran) worsens those symptoms [<xref ref-type="bibr" rid="scirp.102484-ref27">27</xref>]. Similarly, low-FODMAP diet had a favourable impact on IBS symptoms, especially abdominal pain and bloating [<xref ref-type="bibr" rid="scirp.102484-ref28">28</xref>]. Also, rye bread low-FODMAP helps IBS patients control their symptoms and reduces gas distension [<xref ref-type="bibr" rid="scirp.102484-ref29">29</xref>]. However, this finding was limited by the inability to identify the exact amount or weight of the consumed type of food by the patients, besides their similar nutritional habit.</p><p>Abnormally higher scores of neuroticism, extraversion and criminality of EPQ, and anxiety and depression of HSCL-90 were significantly recorded in IBS, where extraversion and criminality of EPQ and depression of HSCL-90 were significantly higher in IBS-C. That agreed with previous studies e.g. Chakrabortiet al who proved neuroticism, hypochondriasis and depression significantly found in IBS patients compared to control subjects [<xref ref-type="bibr" rid="scirp.102484-ref29">29</xref>], and Zhang et al., 2018 who reported more frequent and severer depressive symptoms than healthy controls, particularly in female patients and younger age [<xref ref-type="bibr" rid="scirp.102484-ref30">30</xref>]. On the other hand, the findings in this study partially agreed with other studies e.g. Lee et al. 2017, and Geng et al. 2018 who stated that depression and anxiety levels are higher in IBS patients than in healthy controls, regardless IBS type [<xref ref-type="bibr" rid="scirp.102484-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref32">32</xref>]. Anxiety and depression scores and overall symptom profiles are not significantly different in IBS subtypes. Moreover, anxiety and depression do not appear to be strongly associated with symptom severity, although they may interact with other psychological drivers of severity such as poor adapting skills [<xref ref-type="bibr" rid="scirp.102484-ref33">33</xref>], thus, the efficient mindfulness-based training remarkably reduces symptom severity and improves quality of life [<xref ref-type="bibr" rid="scirp.102484-ref34">34</xref>].</p><p>In this study, only few microbiota showed significant difference between IBS and control subjects. Bacteriodes were significantly high while Klebsiella was significantly low in both IBS groups. On the other hand, Aspergillus was significantly high in IBS-C group; however, fungal detection was generally low. Role of intestinal dysbiosis was proved in many studies but with different and even contradictory results [<xref ref-type="bibr" rid="scirp.102484-ref35">35</xref>] e.g. Jeffery et al., 2012 reported significant decrease of Bacteroids in IBS [<xref ref-type="bibr" rid="scirp.102484-ref36">36</xref>], Si et al., 2004 found significant increase and decrease of Enterobacteriaceae and Bifidobacterium respectively in IBS patients compared with healthy controls [<xref ref-type="bibr" rid="scirp.102484-ref37">37</xref>], Kennedy et al., 2014 found significantly lower Bifidobacteria and Lactobacilli [<xref ref-type="bibr" rid="scirp.102484-ref36">36</xref>], and M&#228;tt&#246; et al., 2005 found slightly higher numbers of coliforms as well as an increased aerobe: anaerobe ratio in IBS [<xref ref-type="bibr" rid="scirp.102484-ref38">38</xref>]. Also, Bifidobacteria were higher in IBS-C yet insignificantly. As a probiotic, Bifidobacterium infantis 35624 efficiently improved IBS symptoms like bloating/distention, abdominal pain/discomfort, and/or bowel movement [<xref ref-type="bibr" rid="scirp.102484-ref39">39</xref>]. However, probiotics showed controversial results in pathogenesis and treatment of IBS that need to be further clarified [<xref ref-type="bibr" rid="scirp.102484-ref40">40</xref>].</p><p>Neither the sympathetic nor the parasympathetic activities, the two components of the ANS, were significantly related to IBS. This agreed with several studies [<xref ref-type="bibr" rid="scirp.102484-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref45">45</xref>], for the applied autonomic activity tests in this study do not reflect the gastrointestinal vagal tone [<xref ref-type="bibr" rid="scirp.102484-ref46">46</xref>]. To the contrary, other studies proved the role of ANS dysfunction in the pathophysiology of IBS [<xref ref-type="bibr" rid="scirp.102484-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref47">47</xref>] [<xref ref-type="bibr" rid="scirp.102484-ref48">48</xref>].</p><p>In this study, correlative tests were done between each two studied aspects including all their items. Both diet and faecal micobiota showed few significant intercorrelation and with psychiatric and autonomic activity parameters as well. The diet provides elements for microbial fermentation, and consequently triggering IBS symptomatology. In addition, definite interaction between certain foods and the intestinal microbiota is likely one of the explanations for the inconclusive findings among studies comparing the microbiota composition in IBS patients and healthy subjects [<xref ref-type="bibr" rid="scirp.102484-ref49">49</xref>]. Thus, Harper et al. 2018 recommended combined therapy of probiotics and low FODMAP diet as the ideal treatment strategy for IBS [<xref ref-type="bibr" rid="scirp.102484-ref50">50</xref>].</p><p>Only psychiatric-autonomic correlation study was completely insignificant. That was contrary to Salvioli et al., 2015 who confirmed that correlation [<xref ref-type="bibr" rid="scirp.102484-ref13">13</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>In this study, psychiatric assessment was the major parameter influencing the pathogenesis of IBS, with incorporation of few micobiota.</p></sec><sec id="s6"><title>Limitation of the Study</title><p>The small number of the included patients for it took us carrying out 335 colonoscopies within one and half year to enroll the designed 20 IBS-D and 20 IBS-C patients to be subjected to the four parameters simultaneously. Also, the applied food frequency questionnaire did not cover all types of foods or fluids nor specify the exact quantity of the ingested type.</p></sec><sec id="s7"><title>Disclosure Statement</title><p>All the authors declare that this study is not published or submitted for publication in any other journal. They all approved this manuscript. They also declare that it is unfunded with no conflict of interest whether personal or financial.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Abdelbary, M., Al-Sayyad, A., Menesy, M., Nasreldin, M., Mostafa, R., Nawito, A. and Marzaban, R. (2020) A Simultaneous Multidisciplinary Evaluation of Irritable Bowel Syndrome in Egyptian Patients: Dietary, Psychiatric, Microbiologic and Autonomic Aspects. Open Journal of Gastroenterology, 10, 214-230. https://doi.org/10.4236/ojgas.2020.108021</p></sec></body><back><ref-list><title>References</title><ref id="scirp.102484-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Drossman, D., Camilleri, M., Mayer, E. and Whitehead, W. (2002) AGA Technical Review on Irritable Bowel Syndrome. Gastroenterology, 123, 2108-2131.https://doi.org/10.1053/gast.2002.37095</mixed-citation></ref><ref id="scirp.102484-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ong, D.K, Mitchell, S.B., Barrett, J.S., Shepherd, S.J., Irving, P.M., Biesiekierski, J.R., Smith, S., Gibson, P.R. and Muir, J.G. (2010) Manipulation of Dietary Short Chain Carbohydrates Alters the Pattern of Gas Production and Genesis of Symptoms in Irritable Bowel Syndrome. Journal of Gastroenterology and Hepatology, 25, 1366-1373. https://doi.org/10.1111/j.1440-1746.2010.06370.x</mixed-citation></ref><ref id="scirp.102484-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Staudacher, H.M., Whelan, K., Irving, P.M. and Lomer, M.C.E. (2011) Comparison of Symptom Response Following Advice for a Diet Low in Fermentable Carbohydrates (FOD-MAPs) versus Standard Dietary Advice in Patients with Irritable Bowel Syndrome. Journal of Human Nutrition and Dietetics, 24, 487-495.https://doi.org/10.1111/j.1365-277X.2011.01162.x</mixed-citation></ref><ref id="scirp.102484-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Occhipinti, K. and Smith, J.W. (2012) Irritable Bowel Syndrome: A Review and Update. Clinics in Colon and Rectal Surgery, 25, 46-52. https://doi.org/10.1055/s-0032-1301759</mixed-citation></ref><ref id="scirp.102484-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Drossman, D.A, Creed, F.H., Olden, K.W., Svedlund, J., Toner, B.B. and Whitehead, W.E. (1999) Psychoscial Aspects of the Functional Gastrointestinal Disorders. Gut, 45, 25-30. https://doi.org/10.1136/gut.45.2008.ii25</mixed-citation></ref><ref id="scirp.102484-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Whitehead, W.E. and Crowell, M.D. (1991) Psychologic Considerations in the Irritable Bowel Syndrome. Gastroenterology Clinics of North America, 20, 249-67.</mixed-citation></ref><ref id="scirp.102484-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Brandt, L.J., Chey, W.D., Foxx-Orenstein, A.E., Schiller, L.R., Schoenfeld, P.S., Spiegel, B.M., Talley, N.J. and Quigley, E.M.M. (2009) American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome. The American Journal of Gastroenterology, 104, S8-S35. https://doi.org/10.14309/00000434-200901001-00002</mixed-citation></ref><ref id="scirp.102484-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Pimentel, M., Chow, E.J. and Lin, H.C. (2000) Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome. The American Journal of Gastroenterology, 95, 3503-3506.</mixed-citation></ref><ref id="scirp.102484-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Bharucha, A.E., Camilleri, M., Low, P.A. and Zinsmeister, A.R. (1993) Autonomic Dysfunction in Gastrointestinal Motility Disorders. Gut, 34, 397-401.https://doi.org/10.1136/gut.34.3.397</mixed-citation></ref><ref id="scirp.102484-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Tougas, G. (2000) The Autonomic Nervous System in Functional Bowel Disorders. Gut, 47, iv78-80. https://doi.org/10.1136/gut.47.suppl_4.iv78</mixed-citation></ref><ref id="scirp.102484-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Malik</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use</article-title><source> Circulation</source><volume> 93</volume>,<fpage> 1043</fpage>-<lpage>1065</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.102484-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Arunodaya, G.R. and Taly, A.B. (1995) Sympathetic Skin Response: A Decade Later. Journal of the Neurological Sciences, 129, 81-89. https://doi.org/10.1016/0022-510X(94)00265-P</mixed-citation></ref><ref id="scirp.102484-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Salvioli, B., Pellegatta, G., Malacarne, M., Pace, F., Malesci, A., Pagani, M. and Lucini, D. (2015) Autonomic Nervous System Dysregulation in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility, 27, 423-430.https://doi.org/10.1111/nmo.12512</mixed-citation></ref><ref id="scirp.102484-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Drossman, D.A. (2006) The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology, 130, 1377-1390. https://doi.org/10.1053/j.gastro.2006.03.008</mixed-citation></ref><ref id="scirp.102484-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C. (2006) Functional Bowel Disorders. Gastroenterology, 130, 1480-1491.https://doi.org/10.1053/j.gastro.2005.11.061</mixed-citation></ref><ref id="scirp.102484-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Eysenck, H.J and Eysenck, S.B.G. (1975) Manual of the Eysenck Personality Questionnaire. Hodder and Stoughton, London. https://doi.org/10.1037/t05462-000</mixed-citation></ref><ref id="scirp.102484-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Derogatis, L., Lipman, R., Reckles, K., Uhlenhuth, E. and Covi, L. (1974) Hopkins Symptom Checklist (HSL). Self-Report Symptom Inventory. Behavioral Science, 19, 1-15. https://doi.org/10.1002/bs.3830190102</mixed-citation></ref><ref id="scirp.102484-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Claus, D. and Schondorf, R. (1999) Sympathetic Skin Response. Electroencephalography and Clinical Neurophysiology, 52, 277-282.</mixed-citation></ref><ref id="scirp.102484-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ewing, D.J., Martyn, C.N., Young, R.J. and Clarke, B.F. (1985) The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes. Diabetes Care, 8, 491-498. https://doi.org/10.2337/diacare.8.5.491</mixed-citation></ref><ref id="scirp.102484-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Soares, R. (2014) Irritable Bowel Syndrome: A Clinical Review. World Journal of Gastroenterology, 20, 12144-12160. https://doi.org/10.3748/wjg.v20.i34.12144</mixed-citation></ref><ref id="scirp.102484-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Talley, N.J. (1999) Irritable Bowel Syndrome: Definition, Diagnosis and Epidemiology. Best Practice &amp; Research Clinical Gastroenterology, 13, 371-384.https://doi.org/10.1053/bega.1999.0033</mixed-citation></ref><ref id="scirp.102484-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N. and Worwell, P. (2007) Guidelines on the Irritable Bowel Syndrome: Mechanisms and Practical Mangament. Gut, 56, 1770-1798.https://doi.org/10.1136/gut.2007.119446</mixed-citation></ref><ref id="scirp.102484-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Meleine, M. and Matricon, J. (2014) Gender-Related Differences in Irritable Bowel Syndrome: Potential Mechanisms of Sex Hormones. World Journal Gastroenterology, 20, 6725-6743. https://doi.org/10.3748/wjg.v20.i22.6725</mixed-citation></ref><ref id="scirp.102484-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Hattori, T. and Fukudo, S. (2006) Effects of Gender on Irritable Bowel Syndrome. Nihon Rinsho, 64, 1549-1551.</mixed-citation></ref><ref id="scirp.102484-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Heitkemper, M. and Jarrett, M. (2008) Irritable Bowel Syndrome: Does Gender Matter? Journal of Psychosomatic Research, 64, 583-587. https://doi.org/10.1016/j.jpsychores.2008.02.020</mixed-citation></ref><ref id="scirp.102484-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Cuomo, R., Andreozzi, P., Zito, F.P., Passananti, V., De Carlo, G. and Sarnelli, G. (2014) Irritable Bowel Syndrome and Food Interaction. World Journal of Gastroenterology, 20, 8837-8845.</mixed-citation></ref><ref id="scirp.102484-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Bijkerk, C.J., de Wit, N.J., Muris, J.W.M., Whorwell, P.J., Knottnerus, J.A. and Hoes, A.W. (2009) Soluble or Insoluble Fibre in Irritable Bowel Syndrome in Primary Care? Randomised Placebo Controlled Trial. BMJ, 339, b3154.https://doi.org/10.1136/bmj.b3154</mixed-citation></ref><ref id="scirp.102484-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Altobelli, E., Del Negro, V., Angeletti, P. and Latella, G. (2017) Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients, 9, 940.https://doi.org/10.3390/nu9090940</mixed-citation></ref><ref id="scirp.102484-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Chakraborti, S.K., Dey, B.K., Ghosh, N., Chaudhury, A.N. and Guha Mazumder, D.N. (1996) Objective Evaluation of Psychological Abnormality in Irritable Bowel Syndrome. Indian Journal of Gastroenterology, 15, 43-45.</mixed-citation></ref><ref id="scirp.102484-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Q.-E., Wang, F., Geng. Q., Zheng, W., Ng, C.H., Ungvari, G.S., Yuan, Z., Mei, S., Wang, G. and Xiang, Y.-T. (2018) Depressive Symptoms in Patients with Irritable Bowel Syndrome: A Meta-Analysis of Comparative Studies. International Journal of Biological Sciences, 14, 1504-1512. https://doi.org/10.7150/ijbs.25001</mixed-citation></ref><ref id="scirp.102484-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Lee, C., Doo, E., Choi, J.M., Jang, S., Ryu, H.-S., Lee, J.Y., Oh, J.H., Park, J.H. and Kim, Y.S., Brain-Gut Axis Research Group of Korean Society of Neurogastroenterology and Motility (2017) The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. Journal of Neurogastroenterology and Motility, 23, 349-362.https://doi.org/10.5056/jnm16220</mixed-citation></ref><ref id="scirp.102484-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Geng, Q., Zhang, Q.-E., Wang, F., Zheng, W., Ng, C.H., Ungvari, G.S., Wang, G. and Xiang, Y.-T. (2018) Comparison of Comorbid Depression between Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Meta-Analysis of Comparative Studies. Journal of Affective Disorders, 237, 37-46. https://doi.org/10.1016/j.jad.2018.04.111</mixed-citation></ref><ref id="scirp.102484-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">de Castro, N.G.R., Miller, V., Carruthers, H.R. and Whorwell, P.J. (2015) Irritable Bowel Syndrome?: A Comparison of Subtypes. Journal of Gastroenterology and Hepatology, 30, 279-285. https://doi.org/10.1111/jgh.12704</mixed-citation></ref><ref id="scirp.102484-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Gaylord, S.A., Palsson, O.S., Garland, E.L., Faurot, K.R., Coble, R.S., Mann, J.D., Frey, W., Leniek. K. and Whitehead, W.E. (2011) Mindfulness Training Reduces the Severity of Irritable Bowel Syndrome in Women: Results of a Randomized Controlled Trial. The American Journal of Gastroenterology, 106, 1678-1688.https://doi.org/10.1038/ajg.2011.184</mixed-citation></ref><ref id="scirp.102484-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Rodi&amp;#241;o-Janeiro, B.K., Vicario, M., Alonso-Cotoner, C., Pascua-García, R. and Santos, J. (2018) A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy, 35, 289-310. https://doi.org/10.1007/s12325-018-0673-5</mixed-citation></ref><ref id="scirp.102484-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Kennedy, P.J., Cryan, J.F., Dinan, T.G. and Clarke, G. (2014) Irritable Bowel Syndrome: A Microbiome-Gut-Brain Axis Disorder? World Journal of Gastroenterology, 20, 14105-14125. https://doi.org/10.3748/wjg.v20.i39.14105</mixed-citation></ref><ref id="scirp.102484-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Si, J.-M., Yu, Y.-C., Fan, Y.-J. and Chen, S.-J. (2004) Intestinal Microecology and Quality of Life in Irritable Bowel Syndrome Patients. World Journal of Gastroenterology, 10, 1802-1805. https://doi.org/10.3748/wjg.v10.i12.1802</mixed-citation></ref><ref id="scirp.102484-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">M&amp;#228;tt&amp;#246;, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A. and Saarela, M. (2005) Composition and Temporal Stability of Gastrointestinal Microbiota in Irritable Bowel Syndrome—A Longitudinal Study in IBS and Control Subjects. FEMS Immunology and Medical Microbiology, 43, 213-222. https://doi.org/10.1016/j.femsim.2004.08.009</mixed-citation></ref><ref id="scirp.102484-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Brenner, D.M., Moeller, M.J., Chey, W.D. and Schoenfeld, P.S. (2009) The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review. The American Journal of Gastroenterology, 104, 1033-1049.</mixed-citation></ref><ref id="scirp.102484-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Lee, B.J., Bak and Y.-T. (2011) Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility, 17, 252-266.https://doi.org/10.5056/jnm.2011.17.3.252</mixed-citation></ref><ref id="scirp.102484-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Jarrett, M.E., Burr, R.L., Cain, K.C., Rothermel, J.D., Landis, C.A. and Heitkemper, M.M. (2008) Autonomic Nervous System Function During Sleep Among Women with Irritable Bowel Syndrome. Digestive Diseases and Sciences, 53, 694-703.https://doi.org/10.1007/s10620-007-9943-9</mixed-citation></ref><ref id="scirp.102484-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Ng, C., Malcolm, A., Hansen, R. and Kellow, J. (2007) Feeding and Colonic Distension Provoke Altered Autonomic Responses in Irritable Bowel Syndrome. Scandinavian Journal of Gastroenterology, 42, 441–446. https://doi.org/10.1080/00365520600965749</mixed-citation></ref><ref id="scirp.102484-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Robert, J.J.T., Orr, W.C. and Elsenbruch, S. (2004) Modulation of Sleep Quality and Autonomic Functioning by Symptoms of Depression in Women with Irritable Bowel Syndrome. Digestive Diseases and Sciences, 49, 1250-1258.https://doi.org/10.1023/B:DDAS.0000037820.54069.6c</mixed-citation></ref><ref id="scirp.102484-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Heitkemper, M., Jarrett, M., Cain, K.C., Burr, R., Levy, R., Feld, A. and Hertig, V. (2001) Autonomic Nervous System Function in Women with Irritable Bowel Syndrome. Digestive Diseases and Sciences, 46, 1276-1284. https://doi.org/10.1023/A:1010671514618</mixed-citation></ref><ref id="scirp.102484-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Elsenbruch, S., Lovallo, W.R. and Orr, W.C. (2001) Psychological and Physiological Responses to Postprandial Mental Stress in Women with the Irritable Bowel Syndrome. Psychosomatic Medicine, 63, 805-813. https://doi.org/10.1097/00006842-200109000-00014</mixed-citation></ref><ref id="scirp.102484-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Park H-J. (2008). Heart Rate Variability as a Measure of Disease State in Irritable Bowel Syndrome. Asian Nursing Research, 2, 5-16.https://doi.org/10.1016/S1976-1317(08)60024-9</mixed-citation></ref><ref id="scirp.102484-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Dobrek, L., Friediger, J., Furga&amp;#322;a, A. and Thor, P.J. (2006) Autonomic Nervous System Activity in IBS Patients Estimated by Heart Rate Variability (HRV). Przeglad Lekarski, 63, 743-747.</mixed-citation></ref><ref id="scirp.102484-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Mazurak, N., Seredyuk, N., Sauer, H., Teufel, M. and Enck, P. (2012) Heart Rate Variability in the Irritable Bowel Syndrome: A Review of the Literature. Neurogastroenterology and Motility, 24, 206-216. https://doi.org/10.1111/j.1365-2982.2011.01866.x</mixed-citation></ref><ref id="scirp.102484-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Rajili&amp;#263;-Stojanovi&amp;#263;, M., Jonkers, D.M., Salonen, A., Hanevik, K., Raes, J., Jalanka, J., de Vos, W.M., Manichanh, C., Golic, N., Enck, P., Philippou, E., Iraqi, F.A., Clarke, G., Spiller, R.C. and Penders, J. (2015) Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena? The American Journal of Gastroenterology, 110, 278-287. https://doi.org/10.1038/ajg.2014.427</mixed-citation></ref><ref id="scirp.102484-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Harper, A., Naghibi, M. and Garcha D. (2018) The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. Foods, 7, 13. https://doi.org/10.3390/foods7020013</mixed-citation></ref></ref-list></back></article>